|
SAR1B expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.312600E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.513800E-01 |
| Normal-vs-Stage2 |
1.495960E-01 |
| Normal-vs-Stage3 |
2.297800E-01 |
| Normal-vs-Stage4 |
1.692420E-01 |
| Stage1-vs-Stage2 |
3.059400E-01 |
| Stage1-vs-Stage3 |
1.806450E-02 |
| Stage1-vs-Stage4 |
2.918200E-02 |
| Stage2-vs-Stage3 |
3.087900E-02 |
| Stage2-vs-Stage4 |
2.421600E-02 |
| Stage3-vs-Stage4 |
7.825000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.014000E-01 |
| Normal-vs-AfricanAmerican |
8.055800E-01 |
| Normal-vs-Asian |
8.396800E-01 |
| Caucasian-vs-AfricanAmerican |
6.125200E-01 |
| Caucasian-vs-Asian |
8.658400E-01 |
| AfricanAmerican-vs-Asian |
7.260200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.915400E-01 |
| Normal-vs-Female |
6.451000E-01 |
| Male-vs-Female |
6.322000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.022400E-01 |
| Normal-vs-Age(41-60Yrs) |
6.196800E-01 |
| Normal-vs-Age(61-80Yrs) |
6.616200E-01 |
| Normal-vs-Age(81-100Yrs) |
2.865800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.323600E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.342500E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.764600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.982200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.592010E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.480440E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.629030E-01 |
| Classical-VS-Follicular |
2.541800E-03 |
| Classical-VS-Other |
5.036200E-01 |
| Classical-VS-Normal |
8.497800E-01 |
| Tall-VS-Follicular |
3.388500E-04 |
| Tall-VS-Other |
9.552200E-01 |
| Tall-VS-Normal |
9.719700E-02 |
| Follicular-VS-Other |
1.348330E-02 |
| Follicular-VS-Normal |
1.050310E-02 |
| Other-VS-Normal |
3.351000E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.912600E-01 |
| Normal-vs-N1 |
1.896390E-01 |
| N0-vs-N1 |
3.698200E-02 |
|
|
